How We Do It

Implementing inpatient, evidence-based, antihistamine-transfusion premedication guidelines at a single academic US hospital


 

Allergic transfusion reactions (ATRs) are a common complication of blood transfusions. Advances in transfusion medicine have significantly decreased the incidence of ATRs; however, ATRs continue to be burdensome for patients and problematic for providers who regularly order packed red blood cells and platelet transfusions. To further decrease the frequency of ATRs, routine premedication with diphenhydramine is common practice and is part of “transfusion culture” in a majority of institutions. In this article, we review the history, practice, and literature of transfusion premedication, specifically antihistamines given the adverse-effect profile. We discuss the rationale and original academic studies, which have supported the use of premedication for transfusions for decades.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Extracorporeal shock wave therapy promising for lymphedema
MDedge Hematology and Oncology
Low event rates with real-world use of rivaroxaban in NOAC
MDedge Hematology and Oncology
FDA: Stop prescribing combo drugs with high-dose acetaminophen
MDedge Hematology and Oncology
Vitamin D deficiency in the oncology setting
MDedge Hematology and Oncology
Understanding the experience of living with non–small-cell lung cancer (NSCLC): a qualitative study
MDedge Hematology and Oncology
Current options and future directions in the systemic treatment of metastatic melanoma
MDedge Hematology and Oncology
Biomarker testing for treatment of metastatic colorectal cancer: role of the pathologist in community practice
MDedge Hematology and Oncology
'I'm going to live forever': the guarantee-time bias
MDedge Hematology and Oncology
Palliative care shortens ICU, hospital stays, review data show
MDedge Hematology and Oncology
ICD-10 price tag going up for doctors
MDedge Hematology and Oncology